Academia

There has been recent optimism—and possibly hype—over so-called NAD boosters. Kaiser Health News (KHN) recently reported on Harvard University researcher David Sinclair, who is taking his own research product, a supplement that boosts nicotinamide adenine dinucleotide (NAD), a cofactor found in all living cells.

Hitachi, Ltd., Jichi Medical University, International University of Health and Welfare and Chuo University have developed fundamental technology to support the early differential diagnosis of concurrent autism spectrum disorder in patients with attention-deficit hyperactivity disorder.

The idea of swallowing a needle seems like a very bad idea. But a research team at MIT has developed a capsule about the size of a blueberry that holds a tiny needle that, after being swallowed, injects insulin into the stomach.

Current tools used to predict prostate cancer progression are generally subjective in nature, leading to differing interpretations among clinicians

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Robert Mahley, founder and president of Gladstone Institutes, an internationally-recognized expert on heart disease, cholesterol metabolism and Alzheimer’s disease, is launching a biotech company to focus on Alzheimer’s disease. The company is called GABAeron.

Although bioterrorism doesn’t get the kind of attention more traditional bombings and shootings receive, the biotech industry and the federal government are paying attention and actively funding and developing countermeasures to potential bioterror, military and public health emergencies.

One side effect of getting older is a weakening immune system.

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

Many non-vegan vegetarians and omnivores are open to including insects in their diet. For vegans, however, that is not an option, a new study from the University of Eastern Finland shows.